90 likes | 180 Vues
This study examines the mRNA expression levels in the hypothalamus in response to CRHr1 antagonist treatment compared to control groups in animal models under restraint conditions. Analysis reveals differential expression profiles of AVP, CRH, GHRH, and SRIF in the PVN, DMH, VMH, and ARC regions.
E N D
Handled Vehicle CRHr1 antagonist Control AVP AVP AVP Restraint AVP AVP AVP PVN
AVP mRNA Expression in PVN 75 Control * Restraint * 50 Mean O.D. 25 0 Handled Vehicle CRHr1 antagonist Treatment
Handled Vehicle Control CRHr1 antagonist CRH CRH CRH Restraint CRH CRH CRH PVN
CRH mRNA Expression in PVN 75 Control * Restraint * * 50 Mean O.D. 25 0 Handled Vehicle CRHr1antagonist Treatment
Handled Vehicle Control CRHr1 antagonist GHRH GHRH GHRH Restraint GHRH GHRH GHRH DMH-VMH&ARC
Hypothalamic GHRH mRNA Expression 150 DMH, VMH & Arc Control GHRH Restraint GHRH 100 * * Mean O.D. 50 0 Handled Vehicle CRHr1 antagonist Treatment Group
Control Handled Vehicle CRHr1 antagonist SRIF SRIF SRIF Restraint SRIF SRIF SRIF DMH-VMH& ARC
Hypothalamic SRIF mRNA Expression 500 DMH, VMH & Arc * Control 400 Restraint * 300 Mean O.D. 200 100 0 Handled Vehicle CRHr1 antagonist Treatment
Handled Vehicle CRHr1 antagonist GHRH GHRH GHRH Control GHRH GHRH GHRH Restraint SRIF SRIF SRIF Control SRIF SRIF SRIF Restraint DMH-VMH& ARC